Physician profile
Ming Liu
NPI 1912017286
$6,392.60
in general payments reported to CMS, 2019-2025
20 companies · $5,544 in 2025
The $5,544 reported for 2025 was more than what 91% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $680 · 2020: $147 · 2024: $21.96 · 2025: $5,544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Food and Beverage: $65.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Food and Beverage | $65.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,544.00 | 2025 | |
| Novartis Pharmaceuticals Corporation | $158.80 | 2019-2020 | |
| Allergan, INC. | $104.20 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $86.32 | 2019 | |
| Incyte Corporation | $83.56 | 2019-2024 | Jakafi |
| E.R. Squibb & Sons, L.L.C. | $53.20 | 2019 | |
| Celgene Corporation | $50.99 | 2019-2020 | |
| Janssen Biotech, INC. | $47.95 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.63 | 2019 | |
| Amgen INC. | $29.15 | 2019 | |
| Foundation Medicine, INC. | $28.61 | 2019-2020 | |
| Rigel Pharmaceuticals, INC. | $25.64 | 2019 | |
| Blueprint Medicines Corporation | $24.98 | 2020 | |
| Lilly USA, LLC | $23.05 | 2019 | |
| Tesaro, INC. | $22.78 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $19.78 | 2019 | |
| Eisai INC. | $16.28 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $15.00 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $12.35 | 2020 | |
| Clovis Oncology, INC. | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ming Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.